Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2009-05-29
2011-10-11
Kim, Jennifer M (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S455000
Reexamination Certificate
active
08034838
ABSTRACT:
The composition for treating neurological disorders such as Alzheimer's Disease is provided. The composition includes a modified flavonoid compound having enhanced binding affinity to metabolic modulating enzymes. The composition is effective to down-regulate beta- and gamma-secretase and up-regulate alpha secretase, which results in a reduction in amyloid proteins.
REFERENCES:
patent: 2006/0137207 (2006-06-01), Caldwell et al.
patent: 2007/0116779 (2007-05-01), Mazzio
patent: 2008/0021096 (2008-01-01), Maher
patent: 2008/0044390 (2008-02-01), Jin et al.
patent: 2008/0292607 (2008-11-01), Mazzio et al.
patent: 2009/0130051 (2009-05-01), Jarrott et al.
Ahrens Milton Joseph
Thompson Daryl Lee
Kim Jennifer M
Renner , Otto, Boisselle & Sklar, LLP
LandOfFree
Composition and method for the treatment of neurological... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for the treatment of neurological..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for the treatment of neurological... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4287109